- Home
- HIMS
as 09-18-2025 3:18pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 10.8B | IPO Year: | N/A |
| Target Price: | $37.20 | AVG Volume (30 days): | 27.6M |
| Analyst Decision: | Hold | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.79 | EPS Growth: | 866.21 |
| 52 Week Low/High: | $15.73 - $72.98 | Next Earning Date: | 11-03-2025 |
| Revenue: | $2,013,538,000 | Revenue Growth: | 88.69% |
| Revenue Growth (this year): | 61.8% | Revenue Growth (next year): | 19.38% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dudum Andrew | HIMS | Chief Executive Officer | Sep 16 '25 | Sell | $53.58 | 175,661 | $9,384,625.36 | 178,235 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Sep 15 '25 | Sell | $55.52 | 145,000 | $8,026,075.61 | 156,192 | |
| Chi Michael | HIMS | Chief Commercial Officer | Sep 15 '25 | Sell | $56.00 | 4,150 | $232,400.00 | 278,654 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Aug 26 '25 | Sell | $43.69 | 11,581 | $505,968.10 | 156,192 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Aug 25 '25 | Sell | $44.53 | 2,571 | $114,486.63 | 150,450 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Aug 18 '25 | Sell | $45.04 | 175,661 | $7,914,734.62 | 178,235 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Aug 13 '25 | Sell | $48.05 | 11,581 | $556,419.57 | 156,192 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Aug 11 '25 | Sell | $51.64 | 2,572 | $132,818.08 | 150,450 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Aug 7 '25 | Sell | $50.58 | 660,000 | $33,384,120.00 | 178,235 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Jun 23 '25 | Sell | $47.25 | 23,107 | $1,091,766.47 | 156,192 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Should Investors Rethink Hims & Hers After FDA Flags Super Bowl Ad and Shares Double in 2025?
Investor's Business Daily
2 days ago
FDA Slams Hims & Hers With A Warning Letter. Investors Slam Hims Stock.
The Wall Street Journal
2 days ago
Stocks to Watch Recap: Hershey, Oracle, New York Times
MT Newswires
2 days ago
Sector Update: Health Care Stocks Mixed Late Afternoon
StockStory
2 days ago
Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why
Yahoo Finance Video
2 days ago
Gold's record high, Rocket Lab equity offering, FDA warns Hims
etf.com
2 days ago
Leverage Shares Launches First 3x Single-Stock ETPs on HOOD, HIMS, UNH and Others
MT Newswires
2 days ago
Sector Update: Health Care Stocks Rise Tuesday Afternoon
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.